Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock

49.83 EUR
+0.18 (+0.36%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, FRE scores 4 out of 10 in our fundamental rating. FRE was compared to 32 industry peers in the Health Care Providers & Services industry. FRE has only an average score on both its financial health and profitability. FRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year FRE was profitable.
  • FRE had a positive operating cash flow in the past year.
  • FRE had positive earnings in 4 of the past 5 years.
  • FRE had a positive operating cash flow in each of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • FRE has a Return On Assets of 2.69%. This is comparable to the rest of the industry: FRE outperforms 53.13% of its industry peers.
  • The Return On Equity of FRE (6.14%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 3.26%, FRE is doing worse than 68.75% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for FRE is significantly below the industry average of 7.02%.
  • The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • The Profit Margin of FRE (5.11%) is better than 93.75% of its industry peers.
  • FRE's Profit Margin has declined in the last couple of years.
  • The Operating Margin of FRE (9.76%) is better than 93.75% of its industry peers.
  • FRE's Operating Margin has declined in the last couple of years.
  • FRE has a better Gross Margin (24.99%) than 62.50% of its industry peers.
  • FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRE is destroying value.
  • FRE has about the same amout of shares outstanding than it did 1 year ago.
  • FRE has more shares outstanding than it did 5 years ago.
  • FRE has a better debt/assets ratio than last year.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • FRE has an Altman-Z score of 2.08. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FRE has a Altman-Z score of 2.08. This is comparable to the rest of the industry: FRE outperforms 50.00% of its industry peers.
  • The Debt to FCF ratio of FRE is 11.17, which is on the high side as it means it would take FRE, 11.17 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 11.17, FRE perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
  • A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.61, FRE belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.08
ROIC/WACC0.62
WACC5.29%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • FRE has a Current ratio of 1.26. This is in the better half of the industry: FRE outperforms 68.75% of its industry peers.
  • A Quick Ratio of 0.99 indicates that FRE may have some problems paying its short term obligations.
  • With a decent Quick ratio value of 0.99, FRE is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 215.74% over the past year.
  • The Earnings Per Share has been decreasing by -2.29% on average over the past years.
  • FRE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.13%.
  • FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.22% yearly.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.78% on average over the next years. This is quite good.
  • Based on estimates for the next years, FRE will show a small growth in Revenue. The Revenue will grow by 4.95% on average per year.
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.78%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.61, which indicates a correct valuation of FRE.
  • Based on the Price/Earnings ratio, FRE is valued a bit cheaper than 68.75% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.47. FRE is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 13.04, which indicates a correct valuation of FRE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FRE indicates a somewhat cheap valuation: FRE is cheaper than 68.75% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.26. FRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.61
Fwd PE 13.04
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than 71.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.41
EV/EBITDA 10.64
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • FRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y12.68%
EPS Next 3Y11.74%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.01%, FRE has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.57, FRE pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

  • FRE pays out 59.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (1/16/2026, 7:00:00 PM)

49.83

+0.18 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners46.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.07B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts85.45
Price Target55.96 (12.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.11%
PT rev (3m)7.95%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)-11.25%
EPS NY rev (1m)1.6%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 14.61
Fwd PE 13.04
P/S 1.26
P/FCF 23.41
P/OCF 12.89
P/B 1.51
P/tB 15.15
EV/EBITDA 10.64
EPS(TTM)3.41
EY6.84%
EPS(NY)3.82
Fwd EY7.67%
FCF(TTM)2.13
FCFY4.27%
OCF(TTM)3.87
OCFY7.76%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.97
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.08
F-Score7
WACC5.29%
ROIC/WACC0.62
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.78%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.95%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.72%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (FRE.DE) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 15% in the next year.


How sustainable is the dividend of FRESENIUS SE & CO KGAA (FRE.DE) stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.